Final Guidance Docs Outline Best Practices For FDA Postmarket Studies
Executive Summary
The agency advises device makers on its recommendations for postmarket surveillance, both when required under a PMA and when conducted under a 522 order.
Topics
- Subjects
- Post Market Regulation & Studies
- Policy
- FDA
- Guidance Documents
- Industries
- Medical Device
- Regions
- North America
Latest Headlines
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
MT145921
Ask The Analyst
Ask the Analyst is free for subscribers. Submit your question and one of our analysts will be in touch.
Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.
All fields are required.
MT145921
Email Article
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.